Accenture, Hewlett Packard Enterprise And 2 Other Stocks Insiders Are Selling

The Nasdaq 100 closed higher on Friday. Investors, meanwhile, focused on some notable insider trades.

When insiders sell shares, it could be a preplanned sale, or could indicate their concern in the company’s prospects or that they view the stock as being overpriced. Insider sales should not be taken as the only indicator for making an investment or trading decision. At best, it can lend conviction to a selling decision.

Below is a look at a few recent notable insider sales. For more, check out Benzinga's insider transactions platform.

Moderna

• The Trade: Moderna, Inc. MRNA Director Noubar B. Afeyan sold a total of 15,000 shares at an average price of $120.42. The insider received around $1.81 million from selling those shares.
• What’s Happening: Merck & Co and Moderna initiated a pivotal Phase 3 randomized V940-001 trial evaluating V940 (mRNA-4157), an investigational individualized neoantigen therapy (INT), in combination with Keytruda, as an adjuvant treatment in patients with resected high-risk (Stage IIB-IV) melanoma.
• What Moderna Does: Moderna is a commercial-stage biotech that was founded in 2010 and had its initial public offering in December 2018.

Have a look at our premarket coverage here

Hewlett Packard Enterprise

• The Trade: Hewlett Packard Enterprise Company HPE SVP Controller and CTO Jeremy Cox sold a total of 21,131 shares at an average price of $17.66. The insider received around $373,173 from selling those shares.
• What’s Happening: Applied Digital collaborated with Hewlett Packard Enterprise to deliver energy-efficient supercomputers that are proven to support large-scale AI.
• What Hewlett Packard Enterprise Does: Hewlett Packard Enterprise is an information technology vendor that provides hardware and software to enterprises.

Exact Sciences

• The Trade: Exact Sciences Corporation EXAS Director James Edward Doyle sold a total of 2,000 shares at an average price of $97.42. The insider received around $194,840 from selling those shares.
• What’s Happening: Exact Sciences recently said its Cologuard test demonstrated 94% sensitivity for colorectal cancer at 91% specificity.
• What Exact Sciences Does: Exact Sciences Corporation, headquartered in Madison, Wisconsin, provides cancer screening and diagnostic test products in the United States and internationally.

Accenture

• The Trade: Accenture plc ACN General Counsel/Corp Secretary Joel Unruch sold a total of 7,000 shares at an average price of $320.60. The insider received around $2.24 million from selling those shares.
• What’s Happening: Accenture announced leadership appointments.
• What Accenture Does: Accenture is a leading global IT-services firm that provides consulting, strategy, and technology and operational services.

Check This Out: Wall Street's Most Accurate Analysts Say Sell These 3 Tech Stocks Delivering High-Dividend Yields